<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03474224</url>
  </required_header>
  <id_info>
    <org_study_id>1822</org_study_id>
    <nct_id>NCT03474224</nct_id>
  </id_info>
  <brief_title>Hemodynamic Optimization During Major Abdominal Surgery</brief_title>
  <official_title>Venous to Arterial Carbon Dioxide Combined to a Targerting Stroke Volume Protocol During Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Policlinico Universitario Agostino Gemelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Policlinico Universitario Agostino Gemelli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective observational study investigators aim to search any relationship between
      the venous to arterial carbon dioxide gap and the time of percentage to adherence too a
      stroke volume guided protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During major abdominal surgery (i.e. cefalopancreasectomy) investigators will use a minimally
      hemodynamic monitoring (Flotrac Monitoring System) to guide fluid therapy; investigators will
      refer to a stroke volume target value obtained by a bolus of Crystalloids. After the
      induction of anesthesia, then each hour during surgery until the end of surgical procedure
      investigators will assess the time of adherence to the hemodynamic protocol and the
      venous-arterial CO2 gap.Investigators expect to find an inverse proportionality between the
      two parameters explored.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 5, 2018</start_date>
  <completion_date type="Anticipated">February 5, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>correlation between the stroke-volume guided fluid therapy and the carbon dioxide venous-to-arterial gap absolute value in mmHg</measure>
    <time_frame>an average of 8 hours</time_frame>
    <description>investigators will optimize fluid therapy in order to achieve the higher value of stroke volume and will verify if the time of SV &gt; 90% of the maximal value is correlated to a value of the carbon dioxide venous-to-arterial gap less than 6 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative overall complications</measure>
    <time_frame>up to 30 days</time_frame>
    <description>investigators will assess the impact of the intraoperative hemodynamic optimization on the rate of postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of hospitalization</measure>
    <time_frame>an average of 2 weeks</time_frame>
    <description>investigators will prospectively evaluate the association between an intraoperative goal-directed fluid therapy with the long of stay</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>FloTrac patients</arm_group_label>
    <description>patients belong to this group will be managed with a stroke volume target hemodynamic protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ev1000 Clinical Platform from Edwards Lifesciences</intervention_name>
    <description>The EV1000 Hemodynamic monitoring platform will be used to guide fluid administration following a volume-based parameter such the stroke volume.</description>
    <arm_group_label>FloTrac patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for major abdominal surgery who met the above mentioned inclusion
        criteria will be enrolled. All patients will belong the only study group in which a
        target-based hemodynamic protocol will be applied
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for abdominal surgery

          -  ASA 1-2-3

        Exclusion Criteria:

          -  pregnancy

          -  obesity with a BMI &gt; 35

          -  controindications to central venous catheter positioning

          -  end-stage renal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Russo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paola Aceto, MD</last_name>
    <phone>0630153212</phone>
    <email>pa.aceto@gmail.com</email>
  </overall_contact>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2018</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Policlinico Universitario Agostino Gemelli</investigator_affiliation>
    <investigator_full_name>Dr.Andrea Russo</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>stroke volume</keyword>
  <keyword>goal directed therapy</keyword>
  <keyword>major abdominal surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

